Label: NUVAIL- liquid

  • Category: PRESCRIPTION MEDICAL DEVICE LABEL
  • DEA Schedule: None
  • Marketing Status: Premarket Notification

Drug Label Information

Updated January 17, 2019

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    NAIL SOLUTION

    Rx Only

  • INTENDED USE

    Nuvail™ is indicated for managing signs and symptoms of nail dystrophy, i.e., nail splitting and nail fragility, for intact or damaged nails. Nuvail coats and adheres to the nail surface preventing direct abrasion and friction on the nail surface while also providing protection against the effects of moisture.

  • PRODUCT DESCRIPTION

    The product is a biocompatible, polymeric solution which forms a uniform film when applied to the nail. The product is dispersed in a non-cytotoxic solution which dries rapidly, adhering to the contours of the nail to form a flexible, waterproof barrier. The film will wear off naturally and must be re-applied as directed to be effective. The film is colorless, transparent and possesses good moisture vapor permeability.

  • INGREDIENTS

    16% Poly (urea-urethane) in organic solvents.

  • CONTRAINDICATIONS

    Do not apply directly to deep, open, or profusely bleeding wounds.

  • WARNINGS AND PRECAUTIONS

    The product is flammable in liquid form; avoid using near open flames and sources of ignition. Use in well-ventilated area. Keep out of reach of children.

    Store at room temperature away from heat. Do not allow product to come into contact with floors, counter tops, furniture or other finished surfaces - will stain.

    May temporarily sting upon application. Persons sensitized to isocyanate should not use this product. Should redness or other signs of irritation appear, discontinue use and consult your healthcare provider.

    Use of other products, ointments, creams or lotions before application of this product may prevent the film from forming correctly and reduce effectiveness.

  • DIRECTIONS FOR USE

    • Application is recommended once a day before bedtime
    • Remove bottle cap, dip applicator into product and wipe off excess on lip of bottle
    • Apply in even strokes to affected nail plate [in entirety], proximal and lateral folds, and the distal tip
    • Allow the product to dry completely before applying pads or clothing
    • Replace cap with applicator on bottle when not in use
    • Clean affected nails with nail polish remover once a week
  • HOW SUPPLIED

    Nuvail Nail Solution is supplied in a:

    15 ml non-sterile bottle with applicator 71403-044-01.

    STORAGE AND SHELF LIFE

    For best results the product should be stored at room temperature (15° to 30°C, 59° to 86°F).

    Avoid storage in excessive heat and humidity. Refer to the bottle label for expiration date.

  • SPL UNCLASSIFIED SECTION

    Manufactured for:
    EPI Health, LLC
    Charleston, SC 29403
    Toll Free: 1-800-499-4468

    www.nuvail-rx.com

    N. Code : HR/DEVICE/MFG/MD/2018/000004
    Made in India

    December 2018

    This product may be covered by one or more of the US Patent Nos. 7,008,997/8,771,725/9,259,436.

    NUV-PI-0617

    Version - 1

  • PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

    71403-044-01

    Rx Only
    Nuvail™
    (poly-ureaurethane, 16%)
    NAIL SOLUTION

    For Topical Use Only
    Not For Ophthalmic Use

    EPIHEALTH
    Advancing Dermatology

    15 mL

    Principal Display Panel - 15 mL Bottle Carton
  • INGREDIENTS AND APPEARANCE
    NUVAIL 
    bandage, liquid liquid
    Product Information
    Product TypePRESCRIPTION MEDICAL DEVICEItem Code (Source)NHRIC:71403-044
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LAURIC ACID (UNII: 1160N9NU9U) (LAURIC ACID - UNII:1160N9NU9U) LAURIC ACID2.4 mg  in 15 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:71403-044-0115 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    PREMARKET NOTIFICATIONK12005905/01/2017
    Labeler - EPI Health, Inc (080638894)